Shelton Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Shelton Capital Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-722	Closed	-$237K	–	707
2024 Q4	$237K	Buy	+722	New	+$245K	0.01%	611
2020 Q3	–	Sell	-1,259	Closed	-$568K	–	764
2020 Q2	$568K	Sell	1,259 -58	-4%	-$25.6K	0.03%	308
2020 Q1	$462K	Sell	1,317 -49	-4%	-$18K	0.03%	305
2019 Q4	$505K	Hold	1,366	–	–	0.03%	349
2019 Q3	$455K	Hold	1,366	–	–	0.03%	371
2019 Q2	$427K	Buy	1,366 +929	+213%	+$278K	0.02%	399
2019 Q1	$1.43K	Sell	437 -992	-69%	-$268K	0.01%	813
2018 Q4	$332K	Hold	1,429	–	–	0.02%	434
2018 Q3	$447K	Hold	1,429	–	–	0.03%	399
2018 Q2	$412K	Hold	1,429	–	–	0.03%	418
2018 Q1	$357K	Sell	1,429 -120	-8%	-$30.6K	0.02%	475
2017 Q4	$370K	Hold	1,549	–	–	0.02%	487
2017 Q3	$344K	Hold	1,549	–	–	0.02%	498
2017 Q2	$351K	Hold	1,549	–	–	0.02%	492
2017 Q1	$309K	Hold	1,549	–	–	0.02%	560
2016 Q4	$282K	Sell	1,549 -564	-27%	-$96.2K	0.02%	646
2016 Q3	$346K	Hold	2,113	–	–	0.03%	514
2016 Q2	$302K	Hold	2,113	–	–	0.03%	553
2016 Q1	$289K	Hold	2,113	–	–	0.03%	577
2015 Q4	$293K	Hold	2,113	–	–	0.03%	548
2015 Q3	$284K	Hold	2,113	–	–	0.03%	563
2015 Q2	$318K	Hold	2,113	–	–	0.03%	557
2015 Q1	$286K	Hold	2,113	–	–	0.03%	616
2014 Q4	$255K	Sell	2,113 -174	-8%	-$20K	0.03%	647
2014 Q3	$259K	Hold	2,287	–	–	0.03%	605
2014 Q2	$274K	Hold	2,287	–	–	0.04%	608
2014 Q1	$293K	Hold	2,287	–	–	0.04%	543
2013 Q4	$283K	Hold	2,287	–	–	0.04%	538
2013 Q3	$269K	Hold	2,287	–	–	0.05%	517
2013 Q2	$257K	Buy	+2,287	New	+$268K	0.05%	492

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Shelton Capital Management's BIO Position: Q1 2025 in Review

Shelton Capital Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 722 shares — an estimated $237K sold.

Shelton Capital Management first reported a position in BIO in Q2 2013 and held it in 30 quarters. The position peaked at $568K in Q2 2020. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

Shelton Capital Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
Shelton Capital Management sold 722 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $237K.
Shelton Capital Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 30 quarters.
Shelton Capital Management's Bio-Rad Laboratories Class A position peaked at $568K in Q2 2020.
436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Shelton Capital Management's 13F filing for Q1 2025, filed 15 May 2025.